- Q2 2024 Rxsight Inc Earnings Call TranscriptAug 05, 2024$40.78 (-2.37%)Earnings
- Q1 2024 Rxsight Inc Earnings Call TranscriptMay 06, 2024$62.84 (+1.88%)Earnings
- Q4 2023 Rxsight Inc Earnings Call TranscriptFeb 28, 2024$56.39 (-2.64%)Earnings
- Rxsight Inc at JPMorgan Healthcare Conference TranscriptJan 10, 2024
- Q3 2023 Rxsight Inc Earnings Call TranscriptNov 09, 2023$23.8 (-4.19%)Earnings
- Q2 2023 Rxsight Inc Earnings Call TranscriptAug 07, 2023$28.84 (-4.09%)Earnings
- Rxsight Inc at Bank of America Global Healthcare Conference TranscriptMay 10, 2023
- Q1 2023 Rxsight Inc Earnings Call TranscriptMay 09, 2023$19.25 (-0.82%)Earnings
- Rxsight Inc at Needham Healthcare Conference (Virtual) TranscriptApr 19, 2023
- Rxsight Inc at Oppenheimer Healthcare Conference (Virtual) TranscriptMar 13, 2023
- Q4 2022 Rxsight Inc Earnings Call TranscriptMar 06, 2023$15.69 (+12.96%)Earnings
- Rxsight Inc at JPMorgan Healthcare Conference TranscriptJan 11, 2023
- Q3 2022 Rxsight Inc Earnings Call TranscriptNov 07, 2022$12.62 (+7.86%)Earnings
- Q2 2022 Rxsight Inc Earnings Call TranscriptAug 08, 2022$15.65 (-0.32%)Earnings
- Q1 2022 Rxsight Inc Earnings Call TranscriptMay 05, 2022$10.61 (-10.54%)Earnings
Rxsight Inc at Needham Healthcare Conference (Virtual) Transcript
Hi. Good afternoon, and thank you for joining us at the 22nd Annual Needham Healthcare Conference. My name is David Saxon. I'm one of the analysts on the medtech equity research team here at Needham & Company. With me today is the RxSight team, including President and CEO, Dr. Ron Kurtz; and CFO, Shelly Thunen.
Instead of a standard presentation, we're going to do a Q&A session. If you do have any questions that you'd like to ask, you can submit them electronically through the Needham conference website or you can feel free to e-mail them to me at [email protected], and I'll do my best to fit them in.
Questions & Answers
So with that, I guess we'll jump into the Q&A. Maybe to start, I wanted to see if you could talk about the procedure volume trends you're seeing during the first quarter and maybe remind us what's assumed in guidance.
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)